393 related articles for article (PubMed ID: 8325957)
1. The combined effect of tumor-produced parathyroid hormone-related protein and transforming growth factor-alpha enhance hypercalcemia in vivo and bone resorption in vitro.
Guise TA; Yoneda T; Yates AJ; Mundy GR
J Clin Endocrinol Metab; 1993 Jul; 77(1):40-5. PubMed ID: 8325957
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor enhances parathyroid hormone-related protein-induced hypercalcemia and bone resorption without inhibiting bone formation in vivo.
Uy HL; Mundy GR; Boyce BF; Story BM; Dunstan CR; Yin JJ; Roodman GD; Guise TA
Cancer Res; 1997 Aug; 57(15):3194-9. PubMed ID: 9242449
[TBL] [Abstract][Full Text] [Related]
3. Expression of human transforming growth factor alpha by Chinese hamster ovarian tumors in nude mice causes hypercalcemia and increased osteoclastic bone resorption.
Yates AJ; Boyce BF; Favarato G; Aufdemorte TB; Marcelli C; Kester MB; Walker R; Langton BC; Bonewald LF; Mundy GR
J Bone Miner Res; 1992 Jul; 7(7):847-53. PubMed ID: 1642153
[TBL] [Abstract][Full Text] [Related]
4. Chinese hamster ovarian cells transfected with human parathyroid hormone-related protein cDNA cause hypercalcemia in nude mice.
Guise TA; Chirgwin JM; Favarato G; Boyce BF; Mundy GR
Lab Invest; 1992 Oct; 67(4):477-85. PubMed ID: 1434529
[TBL] [Abstract][Full Text] [Related]
5. Increased production of tumor necrosis factor by normal immune cells in a model of the humoral hypercalcemia of malignancy.
Sabatini M; Yates AJ; Garrett IR; Chavez J; Dunn JF; Bonewald L; Mundy GR
Lab Invest; 1990 Nov; 63(5):676-82. PubMed ID: 2232714
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic efficacy of a soluble receptor activator of nuclear factor kappaB-IgG Fc fusion protein in suppressing bone resorption and hypercalcemia in a model of humoral hypercalcemia of malignancy.
Oyajobi BO; Anderson DM; Traianedes K; Williams PJ; Yoneda T; Mundy GR
Cancer Res; 2001 Mar; 61(6):2572-8. PubMed ID: 11289133
[TBL] [Abstract][Full Text] [Related]
7. Passive immunization with anti-parathyroid hormone-related protein monoclonal antibody markedly prolongs survival time of hypercalcemic nude mice bearing transplanted human PTHrP-producing tumors.
Sato K; Yamakawa Y; Shizume K; Satoh T; Nohtomi K; Demura H; Akatsu T; Nagata N; Kasahara T; Ohkawa H
J Bone Miner Res; 1993 Jul; 8(7):849-60. PubMed ID: 8352067
[TBL] [Abstract][Full Text] [Related]
8. Effects of parathyroid hormone (PTH)-related protein and PTH on osteoclasts and osteoclast precursors in vivo.
Uy HL; Guise TA; De La Mata J; Taylor SD; Story BM; Dallas MR; Boyce BF; Mundy GR; Roodman GD
Endocrinology; 1995 Aug; 136(8):3207-12. PubMed ID: 7628353
[TBL] [Abstract][Full Text] [Related]
9. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E
Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-6 enhances hypercalcemia and bone resorption mediated by parathyroid hormone-related protein in vivo.
de la Mata J; Uy HL; Guise TA; Story B; Boyce BF; Mundy GR; Roodman GD
J Clin Invest; 1995 Jun; 95(6):2846-52. PubMed ID: 7769125
[TBL] [Abstract][Full Text] [Related]
11. Inhibition by human interleukin-1 alpha of parathyroid hormone-related peptide effects on renal calcium and phosphorus metabolism in the rat.
Tørring O; Turner RT; Carter WB; Firek AF; Jacobs CA; Heath H
Endocrinology; 1992 Jul; 131(1):5-13. PubMed ID: 1319327
[TBL] [Abstract][Full Text] [Related]
12. Tumor resection and antibodies to parathyroid hormone-related protein cause similar changes on bone histomorphometry in hypercalcemia of cancer.
Kukreja SC; Rosol TJ; Wimbiscus SA; Shevrin DH; Grill V; Barengolts EI; Martin TJ
Endocrinology; 1990 Jul; 127(1):305-10. PubMed ID: 2361475
[TBL] [Abstract][Full Text] [Related]
13. Parathyroid hormone-related protein and interleukin-1 alpha synergistically stimulate bone resorption in vitro and increase the serum calcium concentration in mice in vivo.
Sato K; Fujii Y; Kasono K; Ozawa M; Imamura H; Kanaji Y; Kurosawa H; Tsushima T; Shizume K
Endocrinology; 1989 May; 124(5):2172-8. PubMed ID: 2539970
[TBL] [Abstract][Full Text] [Related]
14. Dependence of humoral hypercalcemia of malignancy on parathyroid hormone-related protein expression in the canine anal sac apocrine gland adenocarcinoma (CAC-8) nude mouse model.
Gröne A; Weckmann MT; Blomme EA; Capen CC; Rosol TJ
Vet Pathol; 1998 Sep; 35(5):344-51. PubMed ID: 9754539
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-4 inhibits spontaneous and parathyroid hormone-related protein-stimulated osteoclast formation in mice.
Nakano Y; Watanabe K; Morimoto I; Okada Y; Ura K; Sato K; Kasono K; Nakamura T; Eto S
J Bone Miner Res; 1994 Oct; 9(10):1533-9. PubMed ID: 7817798
[TBL] [Abstract][Full Text] [Related]
16. Effect of transforming growth factor alpha, parathyroid hormone-related protein, or their combination on bone histomorphometry.
Kukreja SC; Rosol TJ; D'Anza JJ; Wimbiscus SA
Bone Miner; 1993 Nov; 23(2):105-11. PubMed ID: 8305876
[TBL] [Abstract][Full Text] [Related]
17. Copurification of osteolytic and transforming growth factor beta activities produced by human lung tumor cells associated with humoral hypercalcemia of malignancy.
Linkhart TA; Mohan S; Jennings JC; Baylink DJ
Cancer Res; 1989 Jan; 49(2):271-8. PubMed ID: 2535957
[TBL] [Abstract][Full Text] [Related]
18. Tumors producing human tumor necrosis factor induced hypercalcemia and osteoclastic bone resorption in nude mice.
Johnson RA; Boyce BF; Mundy GR; Roodman GD
Endocrinology; 1989 Mar; 124(3):1424-7. PubMed ID: 2917519
[TBL] [Abstract][Full Text] [Related]
19. Effects of transforming growth factor-alpha on parathyroid hormone- and parathyroid hormone-related protein-mediated bone resorption and adenylate cyclase stimulation in vitro.
Rosol TJ; Merryman JI; Nohutcu RM; McCauley LK; Capen CC
Domest Anim Endocrinol; 1991 Oct; 8(4):499-507. PubMed ID: 1786699
[TBL] [Abstract][Full Text] [Related]
20. EGF receptor antiserum inhibits bone resorbing activity produced by a rat Leydig cell tumor associated with the humoral hypercalcemia of malignancy.
Ibbotson KJ; D'Souza SM; Smith DD; Carpenter G; Mundy GR
Endocrinology; 1985 Jan; 116(1):469-71. PubMed ID: 2981075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
